Table 1. Measures of chronical ankle instability in the subjects before and after supplementation with SCP or placebo.
| Parameter |
Group |
t1 Mean |
t1 SD |
t2 Mean |
t2 SD |
ANOVA |
| CAIT (Score) |
TG |
15.48† |
4.86 |
20.76*** |
5.42 |
< 0.05 |
| PG |
20.80 |
4.77 |
21.45 |
4.18 |
| FAAM-G ADL (%) |
TG |
81.56† |
12.79 |
91.32*** |
9.91 |
< 0.05 |
| PG |
90.28 |
9.29 |
91.44 |
8.13 |
| FAAM-G Sport (%) |
TG |
60.48† |
18.43 |
80.36*** |
16.90 |
< 0.05 |
| PG |
76.24 |
18.15 |
76.52 |
18.10 |
| Stiffness (N/mm) |
TG |
9.12 |
4.65 |
9.19 |
4.45 |
NS |
| PG |
9.62 |
2.97 |
8.85 |
2.89 |
** p < 0.005 within the group from baseline to final examination*** p <0.001 within the group from baseline to final examination.† significant difference at baseline between treatment group and placebo group (p < 0.05).NS, not significant.* p < 0.05 within the group from baseline to final examination
